Shanxi Zhendong Pharmaceutical Co (SZSE:300158) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shanxi Zhendong Pharmaceutical Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Shanxi Zhendong Pharmaceutical Co's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.00.

Shanxi Zhendong Pharmaceutical Co's long-term debt to total assets ratio stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00).

Shanxi Zhendong Pharmaceutical Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Shanxi Zhendong Pharmaceutical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanxi Zhendong Pharmaceutical Co LT-Debt-to-Total-Asset Chart

Shanxi Zhendong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

Shanxi Zhendong Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Shanxi Zhendong Pharmaceutical Co LT-Debt-to-Total-Asset Calculation

Shanxi Zhendong Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	1.532	/	6180.497
	=	0.00

Shanxi Zhendong Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	0.97	/	5881.625
	=	0.00

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Shanxi Zhendong Pharmaceutical Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Shanxi Zhendong Pharmaceutical Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanxi Zhendong Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

Zhendong Technology Park, Guang Road, Changzhi County, Changzhi, CHN, SXI 047100

Website

http://en.zdjt.com

Shanxi Zhendong Pharmaceutical Co Ltd together with its subsidiaries, researches, develops, manufactures, and markets pharmaceutical products and Chinese medicines in China. It offers anticancer drugs, cardiovascular disease prevention and control drugs and anti-infection drugs among others. The company categorizes its product as Chinese & Western Medicine, Wuhe Food, Home Care Products and Traditional Chinese Medicine.

Executives

Miao Hui	Director
Ma Shi Feng	Executives
Li Zhi Xu	Executives
Li Xi Hai	Director
You Rong Li	Executives
Wang Xu Wen	Executives
Dong Mi Zhu	Directors, executives
Li Ren Hu	Supervisors
Ning Lu Hong	Directors, executives
Wang Li Qing	Supervisors
Jin Zhi Xiang	Supervisors

Shanxi Zhendong Pharmaceutical Co Headlines

No Headlines